August 2013 – Study presented at the International Conference on Pharmacoepidemiology links Zofran to an increased risk for atrial septal defects, ventricular septal defects and atrioventricular septal defects.
August 2013 – Study presented at the International Conference on Pharmacoepidemiology links Zofran to an increased risk for atrial septal defects, ventricular septal defects and atrioventricular septal defects.